To investigate this we have used isogenic cell lines with defined genetically manipulated TP53 status, including p53 null, wild-type, and various loss of function, dominant negative and gain of function mutants, to examine the role of p53 in SCCHN metabolism and have found that p53 is deterministic in this process. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.